| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/23/1991 | EP0409040A1 Antibodies to Promoters of colony stimulating factor activity |
| 01/23/1991 | EP0408859A2 Monoclonal antibodies to activated endothelial cells |
| 01/23/1991 | EP0408663A1 Peptides inhibitors of hiv induced cell fusions and syncytia formation |
| 01/23/1991 | EP0408661A1 Methods of generating desired amino-terminal residues in proteins |
| 01/23/1991 | EP0408649A1 Bone and cartilage inductive compositions |
| 01/23/1991 | EP0387276A4 Method to produce immunodiagnostic reagents |
| 01/23/1991 | EP0189481B1 Insulin-like growth factor ii |
| 01/23/1991 | EP0183780B1 Distinguishing subsets of human cells |
| 01/22/1991 | WO1991002002A1 Recombinantly produced human membrane cofactor protein (mcp) |
| 01/22/1991 | WO1991001332A1 Feline calicivirus capsid protein and nucleotide sequence |
| 01/22/1991 | US4987078 Plasmid vectors for expression in Escherichia coli and/or Bacillus subtilis |
| 01/22/1991 | US4987070 Use of a 97 amino acid leader sequence from the E. coli B-galactosidase gene for the production of hanp and hptc as fusion proteins |
| 01/22/1991 | CA1279276C Polypeptides and antibiotics characteristic of papillomavirus and use for the in vitro diagnostic, the prevention and/or the control of papillomavirus infections |
| 01/20/1991 | CA2020729A1 Bone morphogenetic protein |
| 01/19/1991 | CA2021369A1 Tumor necrosis factor (tnf) inhibitor and method for obtaining the same |
| 01/17/1991 | DE3922453A1 Prod. extracted from milk protein hydrolysate - for topical treatment of herpes simplex virus infections |
| 01/16/1991 | EP0408301A1 DNA coding for a polypeptide signal sequence in vaccinia virus |
| 01/16/1991 | EP0408178A1 Immobilized protein G variants and the use thereof |
| 01/16/1991 | EP0408146A2 Method for the purification of therapeutically active recombinant acidic fibroblast growth factor |
| 01/16/1991 | EP0408063A1 A process for the production of hydrolyzed vegetable proteins and the product therefrom |
| 01/16/1991 | EP0407586A1 Human monoclonal antibody and process for its preparation |
| 01/16/1991 | EP0407543A1 Mammalian gap-43 compositions and methods of use |
| 01/16/1991 | EP0407462A1 Dna binding proteins including androgen receptor |
| 01/16/1991 | EP0407430A1 Therapeutic murine monoclonal antibody |
| 01/16/1991 | EP0407399A1 Immunosupression with anti-pan t-cell immunotoxin compositions |
| 01/16/1991 | EP0227833B1 Process for preparing hetero-protein |
| 01/16/1991 | EP0198086B1 Mouse human hybridoma producing antivirus human antibody, process for its preparation, and antivirus human monoclonal antibody |
| 01/16/1991 | CN1011243B Regulatory site of expression for heterogenetic gene in yeast |
| 01/16/1991 | CA2021147A1 Process for preparing and purifying an anticoagulant |
| 01/15/1991 | WO1991001330A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | US4985361 Genetic engineering |
| 01/15/1991 | US4985356 Cloning of DNA encoding human motilin precursor and expression of the precursor |
| 01/15/1991 | US4985144 Purification of protein antigens |
| 01/15/1991 | CA2062975A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 01/15/1991 | CA2020461A1 Process for the production of hydrolyzed vegetable proteins and the product therefrom |
| 01/15/1991 | CA1279006C Assay for human breast cancer |
| 01/14/1991 | CA2020720A1 Method for the purification of therapeutically active recombinant acidic fibroblast growth factor |
| 01/13/1991 | CA2020740A1 Antigenically active proteins/peptides, and feline infectious peritonitis virus (fipv)-vaccines |
| 01/12/1991 | WO1991000911A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/12/1991 | CA2063389A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 01/11/1991 | WO1991000870A1 Somatotropin analogs |
| 01/11/1991 | CA2057035A1 Somatotropin analogs |
| 01/10/1991 | WO1991000354A1 Nucleic acid coding for the human testicular angiotensin conversion enzyme (eca) and its applications, in particular for the in vitro detection of said enzyme in the organism |
| 01/10/1991 | WO1991000352A1 Pestivirus nucleotide sequences and polypeptides |
| 01/10/1991 | WO1991000351A1 Fungal stress proteins |
| 01/10/1991 | WO1991000349A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/10/1991 | WO1991000347A1 Method of producing proteins with fviii activity and/or fviii derivatives |
| 01/10/1991 | WO1991000295A1 Novel antibodies reactive with human carcinomas |
| 01/10/1991 | WO1991000294A1 Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates |
| 01/10/1991 | WO1991000292A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/10/1991 | WO1991000100A2 Toxin uses |
| 01/10/1991 | WO1990014427A3 Multivalent repressor of gene function |
| 01/10/1991 | WO1990013643A3 Glycoprotein hormone receptor molecules |
| 01/10/1991 | WO1990012874A3 Cysteine added variants of polypeptides and chemical modifications thereof |
| 01/10/1991 | WO1990012807A3 Purified, highly specific antibodies against gene products including retinoblastoma and method |
| 01/10/1991 | CA2059131A1 Compositions and methods for the synthesis of natriuretic protein receptor b and methods of use |
| 01/09/1991 | EP0407259A1 Hybrid proteins between an extracytoplasmic enzyme and at least another protein, preparation and method and application therefor |
| 01/09/1991 | EP0407092A1 Lymphocyte-activating factor, method for the preparation thereof and method for the proliferation of antibody-forming lymphocytes and production of antibody using the same |
| 01/09/1991 | EP0406880A2 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/09/1991 | EP0406725A1 Cyclic tetrapeptide and process for preparing the same |
| 01/09/1991 | EP0406628A1 Monoclonal antibody against endothelin, hybridoma capable of producing the same and radioimmunoassay for endothelin by using the same |
| 01/09/1991 | EP0406557A2 Multivalent repressor of gene function |
| 01/09/1991 | EP0406545A2 Cloned gene encoding for bacteriocin from pediococcus acidilactici |
| 01/09/1991 | EP0406402A1 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
| 01/09/1991 | EP0406367A1 Scavenger receptor protein and antibody thereto |
| 01/09/1991 | EP0406357A1 Functional recombinantly prepared synthetic protein polymer |
| 01/09/1991 | EP0406286A1 Dna encoding a ryegrass pollen allergen |
| 01/09/1991 | EP0406267A1 Non-nuclear chromosomal transformation |
| 01/09/1991 | EP0406259A1 Antibodies, process for producing them, clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours. |
| 01/09/1991 | EP0406257A1 Proteins which induce immunological effector cell activation and chemattraction |
| 01/09/1991 | EP0397704A4 Cereal product |
| 01/08/1991 | WO1991000905A1 Rapid, versatile and simple system for expressing genes in eukaryotic cells |
| 01/08/1991 | WO1990010058A2 Method for production and purification of hepatitis b vaccine |
| 01/08/1991 | US4983722 Exposure to anion exchange material, adsorption, elution |
| 01/08/1991 | US4983529 Immunoassay for HIV-I antigens using F(AB')2 fragments as probe |
| 01/08/1991 | US4983520 DNA sequence encoding modified hepatitis B virus surface antigen P31 protein |
| 01/08/1991 | US4983518 Eukaryotic expression vectors with multimeric enhancer segments, a process for the preparation thereof and the use thereof |
| 01/08/1991 | CA2020593A1 Method for stimulating macrophage activity against tumors and composition therefor |
| 01/07/1991 | WO1991001004A1 Hybrid molecules |
| 01/07/1991 | CA2035868A1 Hybrid molecules |
| 01/06/1991 | CA2020544A1 Monoclonal antibodies involved in alzheimer's disease, hybridomas secreting these monoclonal antibodies, antigen recognized by these antibodies, and their application |
| 01/06/1991 | CA2020543A1 Monoclonal antibodies directed against activated microglia cells, hybridomas secreting these monoclonal antibodies, antigen recognized by these monoclonal antibodies and their applications |
| 01/06/1991 | CA2020303A1 Cytokines |
| 01/03/1991 | CA2009336A1 Cloned gene encoding for bacteriocin from pediococcus acidilactici |
| 01/02/1991 | EP0406122A1 Process for obtaining a native, wild-type human oestrogen receptor and its applications |
| 01/02/1991 | EP0406029A1 Fungal stress proteins |
| 01/02/1991 | EP0405998A1 Antibiotic agents |
| 01/02/1991 | EP0405997A1 Antibiotic agent |
| 01/02/1991 | EP0405980A1 Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 01/02/1991 | EP0405867A1 Novel compounds |
| 01/02/1991 | EP0405858A2 Control of aberrant expression vector accumulation during fermentation procedures |
| 01/02/1991 | EP0405810A2 Novel bacillus thuringiensis isolate active against lepidopteran pests, and genes encoding novel lepidopteran-active toxins |
| 01/02/1991 | EP0405763A1 GRF peptides |
| 01/02/1991 | EP0405467A2 A process for the determination of interleukins |
| 01/02/1991 | EP0404925A1 Method for transforming human b lymphocytes. |
| 01/02/1991 | EP0404912A1 Monoclonal antibodies reactive with defined regions of the t cell antigen receptor |
| 01/02/1991 | EP0404836A1 Human monoclonal antibodies against rabies virus |
| 01/02/1991 | EP0404812A1 Recombinant igf binding protein (ibp-1) |
| 01/02/1991 | CN1048232A Preparation process of edible gelatin by use of skin material enzymic method |
| 01/01/1991 | US4981952 Method for the purification of vitamin K-dependent proteins |